{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:56:31Z","timestamp":1764996991678,"version":"build-2065373602"},"reference-count":39,"publisher":"CSIRO Publishing","issue":"5","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":4337,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10,14]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recent antiretroviral regimens are potent and better tolerated, resulting in a low prevalence of treatment failure. It is important to identify the drivers of virological failure, so that patients at risk can be identified early and prevention strategies implemented. Methods: We performed a retrospective case\u2013control study of HIV-positive patients on antiretroviral therapy and managed at The Alfred Hospital during 2010 to evaluate the predictors of virological failure. Controls were matched 3 : 1 to cases by gender, and by clinical review in the same week as the diagnosis of virological failure in the case. Predictors of virological failure were identified by multivariate conditional logistic regression. Results: Thirty-nine patients were identified with treatment failure. In the multivariate model, characteristics associated with virological failure were missed clinic appointments in 1 year before virological failure (odds ratio (OR) = 13.1, 95% confidence interval (CI): 2.8\u201361.1), multiple previous combined antiretroviral therapy regimens (OR = 4.2, 95% CI:1.2\u201315.3), current hepatitis C infection (OR = 8.6, 95% CI: 1.9\u201338.7), older age at HIV diagnosis (OR = 1.1, 95% CI: 1.0\u20131.2), younger age at time of virological failure (OR = 0.9, 95% CI: 0.8 to 1.0), and CD4 cell count at virological failure (OR = 0.7, 95% CI: 0.5 to 0.9). Conclusions: Targeted and appropriate adherence support should be provided to treatment-experienced patients, particularly those who have missed clinical appointments and those with hepatitis C coinfection. Further elucidation of the barriers to clinic attendance may optimise linkage and retention in care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/sh13043","type":"journal-article","created":{"date-parts":[[2013,10,13]],"date-time":"2013-10-13T23:40:10Z","timestamp":1381707610000},"page":"442-447","source":"Crossref","is-referenced-by-count":12,"title":["Factors associated with virological failure in a cohort of combination antiretroviral therapy-treated patients managed at a tertiary referral centre"],"prefix":"10.1071","volume":"10","author":[{"given":"Raymond","family":"Fong","sequence":"first","affiliation":[{"name":"ADepartment of Infectious Diseases, The Alfred Hospital, Melbourne, Vic. 3004, Australia."},{"name":"CChangi General Hospital, Singapore."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen C.","family":"Cheng","sequence":"additional","affiliation":[{"name":"ADepartment of Infectious Diseases, The Alfred Hospital, Melbourne, Vic. 3004, Australia."},{"name":"BDepartment of Infectious Diseases, Faculty of Medicine, Nursing and Health Science, Monash University, Melbourne, Vic. 3004, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Vujovic","sequence":"additional","affiliation":[{"name":"ADepartment of Infectious Diseases, The Alfred Hospital, Melbourne, Vic. 3004, Australia."},{"name":"BDepartment of Infectious Diseases, Faculty of Medicine, Nursing and Health Science, Monash University, Melbourne, Vic. 3004, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer F.","family":"Hoy","sequence":"additional","affiliation":[{"name":"ADepartment of Infectious Diseases, The Alfred Hospital, Melbourne, Vic. 3004, Australia."},{"name":"BDepartment of Infectious Diseases, Faculty of Medicine, Nursing and Health Science, Monash University, Melbourne, Vic. 3004, Australia."},{"name":"DCorresponding author. Email: Jennifer.Hoy@monash.edu"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"67","published-online":{"date-parts":[[2013,10,14]]},"reference":[{"issue":"13","key":"2025102617074952600_R1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"issue":"2","key":"2025102617074952600_R2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1086\/499044","article-title":"Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.","volume":"42","author":"Spacek","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2025102617074952600_R3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/QAI.0b013e31817dc416","article-title":"Low prevalence of detectable HIV plasma viremia in patients treated with antiretroviral therapy in Burkina Faso and Mali.","volume":"48","author":"Boileau","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"2025102617074952600_R4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/01.qai.0000182627.28595.01","article-title":"Predictors of virologic failure in HIV-1-infected patients starting highly active antiretroviral therapy in Porto Alegre, Brazil.","volume":"40","author":"Tuboi","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"2025102617074952600_R5","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1097\/01.aids.0000174455.01369.ad","article-title":"Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients.","volume":"19","author":"Zaccarelli","year":"2005","journal-title":"AIDS"},{"issue":"9428","key":"2025102617074952600_R6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(04)16589-6","article-title":"Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.","volume":"364","author":"Ledergerber","year":"2004","journal-title":"Lancet"},{"issue":"10","key":"2025102617074952600_R7","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1086\/644768","article-title":"Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.","volume":"49","author":"Deeks","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2025102617074952600_R8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/ije\/dyl286","article-title":"Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).","volume":"36","author":"Gange","year":"2007","journal-title":"Int J Epidemiol"},{"issue":"5","key":"2025102617074952600_R9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/archinte.166.5.521","article-title":"Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002.","volume":"166","author":"Lampe","year":"2006","journal-title":"Arch Intern Med"},{"issue":"5","key":"2025102617074952600_R10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1086\/650537","article-title":"Predicting virologic failure in an HIV clinic.","volume":"50","author":"Robbins","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2025102617074952600_R11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1590\/S0036-46652005000600004","article-title":"Study of antiretroviral mutants in HIV patients with treatment failures and the effect of risk factors in the virological failures.","volume":"47","author":"Taylor-Castillo","year":"2005","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"9","key":"2025102617074952600_R12","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1086\/383572","article-title":"Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy.","volume":"38","author":"Parienti","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2025102617074952600_R13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/10872910151133729","article-title":"Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors.","volume":"15","author":"Knobel","year":"2001","journal-title":"AIDS Patient Care STDS"},{"issue":"8","key":"2025102617074952600_R14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1001\/archinte.160.8.1123","article-title":"Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study.","volume":"160","author":"Paredes","year":"2000","journal-title":"Arch Intern Med"},{"key":"2025102617074952600_R15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1758-2652-13-25","article-title":"Low cholesterol? Don\u2019t brag yet.. hypocholesterolemia blunts HAART effectiveness: a longitudinal study.","volume":"13","author":"M\u00edguez","year":"2010","journal-title":"J Int AIDS Soc"},{"key":"2025102617074952600_R16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2334-9-81","article-title":"Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda.","volume":"9","author":"Ahoua","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2025102617074952600_R17","first-page":"71","article-title":"Demographic, socio-economic, behavioral and clinical factors predicting virologic failure with generic fixed-dose combination antiretroviral therapy before universal health insurance coverage in northern Thailand.","volume":"40","author":"Tsuchiya","year":"2009","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"1","key":"2025102617074952600_R18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/01.qai.0000248351.10383.b7","article-title":"Predictors of antiretroviral treatment failure in an urban HIV clinic.","volume":"44","author":"Robbins","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025102617074952600_R19"},{"issue":"1","key":"2025102617074952600_R20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1071\/SH09039","article-title":"Triple-class HIV antiretroviral therapy failure in an Australian primary care setting.","volume":"7","author":"Bloch","year":"2010","journal-title":"Sex Health"},{"issue":"2","key":"2025102617074952600_R21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1086\/649215","article-title":"Predictors of virologic failure in HIV-1-infected adults receiving first-line antiretroviral therapy in 8 provinces in China.","volume":"50","author":"Ma","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2025102617074952600_R22","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/00002030-200317003-00002","article-title":"Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Cote d\u2019Ivoire.","volume":"17","author":"Djomand","year":"2003","journal-title":"AIDS"},{"issue":"1","key":"2025102617074952600_R23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/QAI.0b013e318042e1c3","article-title":"Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration.","volume":"45","author":"Tuboi","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025102617074952600_R24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1471-2334-8-93","article-title":"Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort study.","volume":"8","author":"Fielding","year":"2008","journal-title":"BMC Infect Dis"},{"key":"2025102617074952600_R25","doi-asserted-by":"publisher","first-page":"S464","DOI":"10.1086\/521114","article-title":"Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV\/AIDS care.","volume":"196","author":"Bedelu","year":"2007","journal-title":"J Infect Dis"},{"key":"2025102617074952600_R26","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1097\/00126334-200212153-00003","article-title":"Measurement of adherence to antiretroviral medications.","volume":"31","author":"Paterson","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"2025102617074952600_R27","first-page":"57","article-title":"Measuring HIV treatment adherence in clinical practice.","volume":"10","author":"Hecht","year":"1998","journal-title":"AIDS Clin Care"},{"key":"2025102617074952600_R28","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1097\/01.qai.0000248337.97814.66","article-title":"Practical and conceptual challenges in measuring antiretroviral adherence.","volume":"43","author":"Berg","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"2025102617074952600_R29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/QAI.0b013e31818d5c37","article-title":"Racial disparities in HIV virologic failure: do missed visits matter?","volume":"50","author":"Mugavero","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"2025102617074952600_R30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/09540129947983","article-title":"Predictors of outpatient medical appointment attendance among persons with HIV.","volume":"11","author":"Catz","year":"1999","journal-title":"AIDS Care"},{"issue":"11","key":"2025102617074952600_R31","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1086\/516778","article-title":"Retention in care: a challenge to survival with HIV infection.","volume":"44","author":"Giordano","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2025102617074952600_R32","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1086\/595705","article-title":"Missed visits and mortality among patients establishing initial outpatient HIV treatment.","volume":"48","author":"Mugavero","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2025102617074952600_R33","first-page":"124","article-title":"Impact of hepatitis C co-infection on response to antiretroviral treatment.","volume":"14","author":"Pulido","year":"2012","journal-title":"AIDS Rev"},{"issue":"12","key":"2025102617074952600_R34","doi-asserted-by":"publisher","first-page":"e8275","DOI":"10.1371\/journal.pone.0008275","article-title":"Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007.","volume":"4","author":"Ballif","year":"2009","journal-title":"PLoS ONE"},{"issue":"11","key":"2025102617074952600_R35","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1086\/340404","article-title":"Clinical experience with human immunodeficiency virus-infected older patients in the era of effective antiretroviral therapy.","volume":"34","author":"Grimes","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2025102617074952600_R36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1525-1497.2002.09004.x","article-title":"How well do clinicians estimate patients\u2019 adherence to combination antiretroviral therapy?","volume":"17","author":"Miller","year":"2002","journal-title":"J Gen Intern Med"},{"issue":"9327","key":"2025102617074952600_R37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","article-title":"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.","volume":"360","author":"Egger","year":"2002","journal-title":"Lancet"},{"key":"2025102617074952600_R38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2334-4-46","article-title":"Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy.","volume":"4","author":"Tumbarello","year":"2004","journal-title":"BMC Infect Dis"},{"key":"2025102617074952600_R39","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.1093\/cid\/ciq043","article-title":"Introduction: linkage, engagement, and retention in HIV care: essential for optimal individual- and community-level outcomes in the era of highly active antiretroviral therapy.","volume":"52","author":"Mayer","year":"2011","journal-title":"Clin Infect Dis"}],"container-title":["Sexual Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/10\/5\/442\/1254654\/sh13043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/10\/5\/442\/1254654\/sh13043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:07:54Z","timestamp":1761512874000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/sh\/article\/10\/5\/442\/184874\/Factors-associated-with-virological-failure-in-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,14]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10,14]]}},"URL":"https:\/\/doi.org\/10.1071\/sh13043","relation":{},"ISSN":["1448-5028","1449-8987"],"issn-type":[{"type":"print","value":"1448-5028"},{"type":"electronic","value":"1449-8987"}],"subject":[],"published":{"date-parts":[[2013,10,14]]}}}